Fluidigm GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. New Products Posted to GenomeWeb: Fluidigm, Waters, MicroGenDx, More Fluidigm Q1 Revenues Grow 19 Percent The firm adjusted its 2021 revenue guidance range downward due to COVID-19 testing uncertainty, partially offset by expected growth in its core omics tools business. DARPA Programs Leveraging Host-Response Testing, CRISPR for Future Pandemic Preparedness Premium DARPA program managers said they are developing different testing modalities that are crucially linked in their objective to facilitate more comprehensive and faster testing. Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. Mar 1, 2021 FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit Feb 19, 2021 Fluidigm Loses Patent Suit Against IonPath Feb 11, 2021 Fluidigm CEO Lays Out Plan for 'Durable' Diagnostics, Clinical Business Post-COVID Premium Feb 10, 2021 Fluidigm Q4 Revenues Grow 38 Percent on COVID-19-Driven Microfluidics Growth Jan 21, 2021 Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay Dec 18, 2020 People in the News: New Appointments at Fluidigm, Danaher, Guardant Health Nov 25, 2020 In Brief This Week: Fluidigm, Centogene, Ginkgo Bioworks, Applied DNA Sciences, More Nov 5, 2020 Fluidigm Q3 Revenues Jump 50 Percent Driven by COVID-19 Testing Nov 2, 2020 GenomeWeb Index Up 5 Percent in October as Favorable Earnings Reports Bolster Shaky Market Oct 19, 2020 Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing Oct 8, 2020 Fluidigm to Offer Coronavirus Saliva Test to US Colleges, Universities at Low Cost Sep 29, 2020 Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production Sep 8, 2020 Fluidigm Raises $20.9M in Equity Offering, Will Receive $11M After Achieving NIH Milestone Sep 4, 2020 Stanford Team Develops Improved Approach for Single-Cell Metabolic Profiling Premium Aug 27, 2020 As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit Aug 26, 2020 Fluidigm Saliva Test for SARS-CoV-2 Gets FDA Emergency Use Authorization Aug 6, 2020 Fluidigm Q2 Revenues Fall 8 Percent but Beat Analysts' Estimates Aug 4, 2020 GenomeWeb Index Up 13 Percent in July as Investors Cheer COVID Dx Development Aug 4, 2020 Fluidigm, De Novo Software Ink Distribution Deal Jul 31, 2020 NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.